Carregant...
PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
Proton beam therapy (PBT) combined with chemotherapy, such as cis-diamminedichloroplatinum (II) (CDDP) and 5-fluorouracil (5-FU), has been employed as an alternative approach to improve clinical outcomes. PBT has been reported to be effective against esophageal cancer. However, apart from 5-FU and C...
Guardat en:
| Publicat a: | J Radiat Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246074/ https://ncbi.nlm.nih.gov/pubmed/31976528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrz088 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|